New York, NY -- (SBWIRE) -- 01/08/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Array Biopharma Inc (NASDAQ:ARRY), Cumulus Media Inc (NASDAQ:CMLS), Integrated Device Technology Inc (NASDAQ:IDTI), XOMA Corp (NASDAQ:XOMA)
Array Biopharma Inc (NASDAQ:ARRY) showed a volume of 1.95 million shares by the end of last trade whereas the average volume of the stock remained 1.82 million shares. The stock opened the session at $4.93but then moved to $5.16. At that price, the stock showed a positive performance of 5.52%. Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. The drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target pathways. The Company’s drug candidates include AMG 151, MEK162, ARRY-380, ARRY-520, ARRY-543 and ARRY-614.
Will ARRY Continue To Move Higher? Find Out Here
Cumulus Media Inc (NASDAQ:CMLS) opened the session at $8.13 and closed the session at $8.00. The stock showed a negative performance of -0.99% in previous trading session. Traded with volume of 1.83 million shares in the prior session and the average volume of the stock remained 1.23 million shares. Cumulus Media Inc. (Cumulus) owns and operates commercial radio station clusters throughout the United States. At December 31, 2011, it owned or operated approximately 570 radio stations (including under local marketing agreements (LMAs)) in 120 United States media markets and operated nationwide radio networks serving over 4,500 affiliates. At December 31, 2011, under LMAs, it provided sales and marketing services for seven radio stations in the United States. On August 1, 2011, the Company acquired Cumulus Media Partners, LLC. On September 16, 2011, it acquired Citadel Broadcasting Corporation.
Has CMLS Found The Bottom And Ready To Gain Momentum? Find Out Here
Integrated Device Technology Inc (NASDAQ:IDTI) opened the session at $9.88 and closed the session at $9.75. The stock showed a negative performance of -1.22% in previous trading session. Traded with volume of 1.81 million shares in the prior session and the average volume of the stock remained 1.49 million shares. The beta of the stock remained 1.66. Integrated Device Technology, Inc. (IDT) designs, develops, manufactures and markets a broad range of low-power mixed signal semiconductor solutions for the advanced communications, computing and consumer industries. The Company operates in the Communications segment and the Computing and Consumer segment. The Company offers communications solutions for customers within the enterprise, data center and wireless markets. Its computing products are designed specifically for storage and server applications and personal computers,
Why Should Investors Buy IDTI After the Recent Fall? Just Go Here and Find Out
XOMA Corp (NASDAQ:XOMA) the stock decreased -0.85% and finished the session at $7.00. Traded with volume of 1.81 million shares in the prior session and the average volume of the stock remained 2.49 million shares. The beta of the stock remained 2.41. XOMA Corporation (XOMA) is engaged in the discovery and development of antibody-based therapeutics. The Company’s lead drug candidate is gevokizumab (formerly XOMA 052), a humanized monoclonal allosteric modulating antibody designed to inhibit the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta). The Company’s preclinical pipeline includes classes of antibodies that activate or sensitize the insulin receptor in vivo, named XMet, and represent potential new therapeutic approaches to the treatment of diabetes and several diseases that have insulin involvement.
Will XOMA Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)